NT
The startup develops small molecule drugs that enhance the efficacy of chemotherapy and immunotherapy for treatment-resistant cancers. Their platform facilitates the transfer of technology assets from leading research institutes, enabling the creation of a diverse portfolio of biotech investments with measurable returns.
Updated 18 months ago
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops small molecule drugs that enhance the efficacy of chemotherapy and immunotherapy for treatment-resistant cancers. Their platform facilitates the transfer of technology assets from leading research institutes, enabling the creation of a diverse portfolio of biotech investments with measurable returns.